Second Sight Medical Products
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.57-0.37-0.65-0.39-0.96-0.23-0.17-468.65-947.24-1.63-0.60
Price/Sales ratio
67.103.861.463.293.461.181.736.97K32.50K33.31K3.37
Price/Book Value ratio
-11.380.370.641.173.492.660.80-10.370.120.133.07
Price/Cash Flow ratio
-6.02-0.76-0.63-0.52-1.15-0.27-0.21-0.41-919.71-1.66-0.71
Price/Free Cash Flow ratio
-5.94-0.74-0.61-0.51-1.13-0.27-0.20-0.40-918.31-1.65-0.70
Price/Earnings Growth ratio
0.11-0.000.01-0.000.06-0.010.034.6823.68-0.040.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-259.71%-4.71%40.86%-152.84%35.74%29.11%36.31%50%50%50%-58.54%
Operating Profit Margin
-1150.05%-624.90%-223.98%-833.37%-359.22%-510.15%-1004.85%-1489600%-3431.15%-2059205%-434.68%
Pretax Profit Margin
-1467.72%-1035.98%-223.66%-832.59%-358.06%-508.90%-994.14%-1488%-3431.15%-2037277.30%-433.48%
Net Profit Margin
-1467.72%-1035.98%-223.66%-832.59%-358.06%-508.90%-994.14%-1488%-3431.15%-2037277.30%-433.48%
Effective Tax Rate
N/A19.69%-0.28%-0.09%-0.32%-0.24%-1.07%-100007.52%-134.51%N/A-0.20%
Return on Assets
-181.23%-81.73%-70.87%-197.37%-196.70%-328.53%-202.37%-0.33%-0.01%-8.06%-197.03%
Return On Equity
249.09%-101.68%-98.79%-297.62%-361.78%-1137.93%-461.74%2.21%-0.01%-7.85%-329.70%
Return on Capital Employed
-180.15%-61.33%-98.93%-297.90%-362.96%-1140.72%-352.21%2216.66%-0.01%-8.49%-330.43%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/A0.83N/A22.14N/A
Quick Ratio
3.404.282.322.091.580.831.730.8328.6321.751.83
Cash ratio
0.020.070.020.090.090.581.620.6128.2621.750.09
Days of Sales Outstanding
109.3076.0161.2125.0983.9126.6749.14N/AN/AN/A55.29
Days of Inventory outstanding
152.16586.97566.08123.74192.59242.68174.52N/AN/AN/A217.63
Operating Cycle
261.46662.98627.29148.84276.51269.36223.67N/AN/AN/A272.93
Days of Payables Outstanding
20.3852.6348.9641.8753.6497.44185.38354.78K1.45M2.71M47.75
Cash Conversion Cycle
241.08610.35578.33106.96222.86171.9138.29-354.78K-1.45M-2.71M197.39
Debt Ratios
Debt Ratio
1.72N/AN/AN/AN/AN/A0.150.490.000.03N/A
Debt Equity Ratio
-2.37N/AN/AN/AN/AN/A0.35-3.270.000.04N/A
Long-term Debt to Capitalization
1.92N/AN/AN/AN/AN/A0.24N/A0.00N/AN/A
Total Debt to Capitalization
1.92N/AN/AN/AN/AN/A0.261.430.00N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1.33KN/A
Cash Flow to Debt Ratio
-0.90N/AN/AN/AN/AN/A-10.61-7.64-0.03N/AN/A
Company Equity Multiplier
-1.371.241.391.501.833.462.28-6.631.031.042.65
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-11.13-5.03-2.29-6.29-3.00-4.32-8.17-16.82K-35.33-20.02K-3.66
Free Cash Flow / Operating Cash Flow Ratio
1.011.031.031.011.011.001.011.011.001.001.00
Cash Flow Coverage Ratio
-0.90N/AN/AN/AN/AN/A-10.61-7.64-0.03N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-116.57-7.64-0.04-34.47N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A